Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Atossa Therapeutics, Inc.

NASDAQ: ATOS · Life Sciences · 5 alerts · CIK 1488039

Share price
$1.93Close, Nov 16
Market cap
$19.3M
Shares outstanding
9.98MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Atossa Therapeutics, Inc. filings on SEC EDGAR ↗

8:15 AM ET 8-K
Dividend

Atossa Therapeutics Dividend

Atossa Therapeutics declared a dividend of one stapled contingent value right (CVR) for each share of common stock to participate in the potential future monetization of a priority review voucher. The CVRs entitle holders to 25% of the net proceeds from the sale or monetization of the first qualifying FDA priority review voucher awarded to the company, subject to an aggregate payment cap of $50 million. The rights are currently stapled to the common stock and expire on December 31, 2036, if no voucher is awarded.

Counterparty
VStock Transfer, LLC
Term
through Dec 2036

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.